
Spdy Pharma Private Limited
About Spdy Pharma Private Limited
Data last updated:
Spdy Pharma Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24299GJ2020PTC116411. Its GSTIN is 24ABECS4244E1ZM (Gujarat).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.25 Cr. It is led by directors including Yash Banker and Sachi Banker.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Bankers Cardiology Pvt Ltd Nr.Tagore Nagar Opp. Surya Kiran Complex O P Road, Vadodara, Gujarat, India – 390007.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.14 Cr, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹1.03 Cr (net margin 32.9%) and EBITDA of ₹1.41 Cr (EBITDA margin 44.8%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years.
As per MCA filings, the company has open charges of ₹75 Lakh on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹1 Cr; the latest was in February 2021.
Company details
Contact details
Spdy Pharma Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Bankers Cardiology Pvt Ltd Nr.Tagore Nagar Opp. Surya Kiran Complex O P Road, Vadodara, Gujarat, India – 390007
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Spdy Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Spdy Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Spdy Pharma Private Limited, buy the company report.
Financials of Spdy Pharma Private Limited
FY 2025 filings availableSpdy Pharma Private Limited reported revenue of ₹3.14 Cr (up 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over three years, including 38% growth in the latest year. EBITDA rose 65% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.41 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.03 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 44.8% | ||||
| Net Profit Margin | 32.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spdy Pharma Private Limited, buy the company report.
Board of directors of Spdy Pharma Private Limited
Spdy Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yash Banker | Director | 04 Dec 2021 | 4 Years 11 Months | Current |
| Sachi Banker | Director | 04 Dec 2021 | 4 Years 11 Months | Current |
| Jigneshkumar Bhupendrabhai Patel Also directs: Sumukh Associates LLP | Director | 04 Dec 2021 | 4 Years 11 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Sep 2025 | 101167018 | Axis Bank Limited | ₹75 Lakh | Open |
Total charge records: 1 View all charges
Deals & funding
Spdy Pharma Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹1 Cr; the latest was in February 2021.
To see the full deal history of Spdy Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Spdy Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spdy Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Spdy Pharma Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
Spdy Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24ABECS4244E1ZM | Gujarat | Active | 25 Nov 2020 |
To see the full GST registrations and return filing status of Spdy Pharma Private Limited, buy the company report.
Recent activity
Spdy Pharma Private Limited has 8 board changes on record since 2021: 3 appointments and 5 cessations. The latest: Jigneshkumar Bhupendrabhai Patel ceased to be Additional Director on 28 Sep 2022.
Frequently asked questions
Spdy Pharma is an active private limited company based in Vadodara, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 September 2020 (6+ years old) and is registered under CIN U24299GJ2020PTC116411.
Spdy Pharma has 3 current directors:
- Yash Banker - Director
- Sachi Banker - Director
- Jigneshkumar Bhupendrabhai Patel - Director
The latest financial statements of Spdy Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Spdy Pharma is 24ABECS4244E1ZM, registered in Gujarat.
The CIN (Corporate Identification Number) of Spdy Pharma is U24299GJ2020PTC116411. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spdy Pharma was incorporated on 11 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Spdy Pharma has 1 deal on record (1 funding round), with disclosed funding of ₹1 Cr; the latest was in February 2021.
Jigneshkumar Bhupendrabhai Patel ceased to be Additional Director on 28 Sep 2022. Sachi Banker ceased to be Additional Director on 28 Sep 2022. Yash Banker ceased to be Additional Director on 28 Sep 2022. Spdy Pharma has 8 board changes on record in total.
The registered office of Spdy Pharma is at CO Bankers Cardiology Pvt Ltd Nr.Tagore Nagar Opp. Surya Kiran Complex O P Road, Vadodara, Gujarat, India – 390007.
Spdy Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

